Contact
Please use this form to send email to PR contact of this press release:
InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study
TO:
Please use this form to send email to PR contact of this press release:
InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study
TO: